(Q45877732)

17 December 2017

title

Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates (English)

1 reference

17 December 2017

author name string

Lin Y

1

1 reference

17 December 2017

Yang X

2

1 reference

17 December 2017

Chevrier MC

3

1 reference

17 December 2017

Craven S

4

1 reference

17 December 2017

Barrowcliffe TW

5

1 reference

17 December 2017

Lemieux R

6

1 reference

17 December 2017

Ofosu FA

7

1 reference

17 December 2017

publication date

1 September 2004

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

10

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

459-469

1 reference

17 December 2017

The size of human factor VIII heterodimers and the effects produced by thrombin

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00957.X

First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00957.X

Increased proportion of B cell hybridomas secreting monoclonal antibodies of desired specificity in cultures containing macrophage-derived hybridoma growth factor (IL-6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00957.X

The use of recombinant factor VIII products in previously treated patients with hemophilia A: pharmacokinetics, efficacy, safety, and inhibitor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00957.X

Inhibitors: resolving diagnostic and therapeutic dilemmas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00957.X

Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00957.X

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00957.X

Incidence of inhibitors in haemophilia A patients--a review of recent studies of recombinant and plasma-derived factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00957.X

10.1111/J.1365-2516.2004.00957.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017